ABOUT
About us
Vision&Mission
History
Location
Global Network
PRODUCT
Pharmaceuticals
Medical devices
Skin Boosters
R&D
Pipe Line
CONTACT
Announcements
News
Inquiry
EN
KR
EN
ABOUT
About us (CEO greetings)
Vision&Mission
History
Location
Global Network
PRODUCT
Pharmaceuticals
Medical devices
Skin Boosters
R&D
Pipe Line
CONTACT
Announcements
News
Inquiry
ABOUT
ABOUT
ABOUT
PRODUCT
R&D
CONTACT
History
About us
(CEO greetings)
Vision&Mission
History
Location
Global Network
ABOUT
About us
(CEO greetings)
Vision&Mission
History
Location
Global Network
History
HOME
ABOUT
History
BMI Korea has been based on constant challenges and
innovation since its establishment We are growing into a
dynamically moving company
for the
healthy life
of mankind
2016 ~ Present
2011 ~ 2015
2005~ 2010
2020
Completion of new storage and Animal Laboratory in
E wing of Jeju plant
Begun construction a plant in Osong, Chungcheongbuk-do Province
2019
GMP certification for 2nd floor of D wing at Jeju plant
(pre-filled injections)
2018
GMP certification for 1st floor of D wing at Jeju plant
(vial injections)
2017
GMP certification for Jeju plant (solutions)
CGMP Sterile plant construction including Botulinum Toxin formulation
- Botulinum Toxin formulation: IND approval
(export license)
2016
Prize of Prime Minister on facilitating regional economy
Prize of Jeju Government on Developing economy of Jeju
2015
Selected as a leading company of Jeju
2014
BGMP approval for Jeju API facility by KFDA
Certification of a small business company with innovative technologies (Ministry of SMEs and startups)
Certification for excellent employment
by Jeju Governing Province
2013
BGMP approval for Jeju API facility (KFDA)
National project : Development of a combination drug preventing after-cataract
Development of a new drug for lymphocytopenia treatment
2012
National project : Research on original technology for developing medication from natural resources of Mt. Halla
KFDA approval for Hirax injection
2011
GMP certification for Jeju plant (injections)
National project : treatment for metastatic renal cell carcinoma (mRCC)
(human recombinant interleukin-2)
2010
GMP certification for Jeju plant (tablets)
Completion of Jeju cGMP plant construction
2009
Began Jeju cGMP Plant construction
2007
Began export to South Asia, Middle East and South America
2006
Certification for a venture capital company (Korea Technology Finance Corporation)
Certification for the company affiliated laboratory (Korea Industrial Technology Association)
2005
BMI Korea established
Took over GMP Plant in Hyangnam, Gyeonggi Province